July 18, 2024
The Centers for Medicare and Medicaid Services (CMS) released the 2025 Medicare Physician Fee Schedule (MPFS) proposed rule July 10, that includes a conversion factor (CF) of $32.35, which is approximately 2.8% below the current CF of $33.28. The decrease is due to the expiration of a 2.93% update Congress added to the MPFS CF for 2024.

Year-over-year reductions in the conversion factor repeatedly demonstrate that the current Medicare payment system is unsustainable. The American College of Radiology® (ACR®) continues to work with the physician and non-physician community to urge Congress to substantively reform the Medicare physician payment system via the addition of an inflationary update to the MPFS, adjustments to the MPFS budget neutrality requirements, and reforms to the Medicare Access and CHIP (Children’s Health Insurance Program) Reauthorization Act of 2015.

Congress must act to provide physicians with the fiscal stability needed to ensure seniors have access to high quality care.

For more information or if you have questions, contact Rebecca Spangler, Senior Government Relations Director.

Related ACR News

  • Make America Healthy Again

    President Trump released an Executive Order (EO) establishing the "Make America Healthy Again (MAHA) Commission,” Feb. 13 to be led by the new Department of Health and Human Services Secretary Robert F. Kennedy Jr.

    Read more
  • Scope of Practice Bills Introduced At State Legislative Level

    The American College of Radiology® (ACR®) is tracking more than 58 scope of practice bills across 22 states with more expected to be considered.

    Read more
  • ACR Others Challenge MAC Position on Minimally Invasive Arthrodesis of the Sacroiliac Joint

    The American College of Radiology® (ACR®) and other medical specialty societies that use or perform interventional pain and spine procedures told three of the seven Medicare Administrative Contractors (MACs) that implementation of a new policy as written could limit access to a safe, effective and durable treatment option, potentially exacerbating healthcare disparities among Medicare patients.

    Read more